VBC103
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VBC103, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of VBC103 in Patients With Advanced Malignant Solid Tumors [Phase 1, Phase 2]